Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: A competing risk analysis

Urology

Volumn 83, Issue 4, 2014, Pages 863-868

  Messer, Jamie C ^a   Shariat, Shahrokh F ^b   Dinney, Colin P ^c   Novara, Giacomo ^d   Fradet, Yves ^e   Kassouf, Wassim ^f   Karakiewicz, Pierre I ^g   Fritsche, Hans Martin ^h   Izawa, Jonathan I ⁱ   Lotan, Yair ^j   Skinner, Eila C ^k   Tilki, Derya ^l   Ficarra, Vincenzo ^d   Volkmer, Bjoern G ^m   Isbarn, Hendrik ⁿ   Wei, Caimiao ^c   Lerner, Seth P ^o   Curiel, Tyler J ^p   Kamat, Ashish M ^c   Svatek, Robert S ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITÉ LAVAL   (Canada)

^f MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^g UNIVERSITÉ DE MONTRÉAL   (Canada)

^h UNIVERSITY OF REGENSBURG   (Germany)

ⁱ UNIVERSITY OF WESTERN ONTARIO   (Canada)

^j UNIVERSITY OF TEXAS AT DALLAS   (United States)

^k UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^l LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^m UNIVERSITY OF ULM   (Germany)

ⁿ UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^o BAYLOR COLLEGE OF MEDICINE   (United States)

^p UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADVANCED CANCER; ARTICLE; BLADDER CARCINOMA; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL FEATURE; COHORT ANALYSIS; CONFOUNDING VARIABLE; CONTROLLED STUDY; CYSTECTOMY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA;

CARCINOMA; CYSTECTOMY; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84897424398     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.10.060     Document Type: Article

References (22)

1. M. Cardenas-Turanzas, C. Cooksley, and C.A. Pettaway et al. Comparative outcomes of bladder cancer Obstet Gynecol 108 2006 169 175
2. L. Reis, C. Kosary, and B. Hankey SEER Cancer Statistics Reviews, 1973-1996 1997 National Cancer Institute Bethesda
3. E. Scosyrev, K. Noyes, and C. Feng et al. Sex and racial differences in bladder cancer presentation and mortality in the US Cancer 115 2009 68 74
4. A. Micheli, A. Mariotto, and A. Giorgi Rossi et al. The prognostic role of gender in survival of adult cancer patients. EUROCARE Working Group Eur J Cancer 34 1998 2271 2278
5. N.A. Mungan, K.K. Aben, and M.P. Schoenberg et al. Gender differences in stage-adjusted bladder cancer survival Urology 55 2000 876 880
6. L.A. Kiemeney, J.W. Coebergh, and N.P. Koper et al. Bladder cancer incidence and survival in the south-eastern part of The Netherlands, 1975-1989 Eur J Cancer 30A 1994 1134 1137
7. N.E. Fleshner, H.W. Herr, and A.K. Stewart et al. The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society Cancer 78 1996 1505 1513
8. N.A. Mungan, L.A. Kiemeney, and J.A. van Dijck et al. Gender differences in stage distribution of bladder cancer Urology 55 2000 368 371
9. M. May, P.J. Bastian, and S. Brookman-May et al. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a Urol Oncol 31 2013 1141 1147
10. M. May, C. Stief, and S. Brookman-May et al. Gender-dependent cancer-specific survival following radical cystectomy World J Urol 30 2012 707 713
11. R. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
12. J. Fine, and R. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
13. L.A. Gloeckler Ries, M.E. Reichman, and D.R. Lewis et al. Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program Oncologist 8 2003 541 552
14. A.P. Noon, P.C. Albertsen, and F. Thomas et al. Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients Br J Cancer 108 2013 1534 1540
15. R.S. Svatek, E.B. Avritscher, and L. Elting et al. High risk populations and cystectomy outcomes J Urol 182 2009 10 11
16. R. Madeb, and E.M. Messing Gender, racial and age differences in bladder cancer incidence and mortality Urol Oncol 22 2004 86 92
17. S. Mommsen, J. Aagaard, and A. Sell Presenting symptoms, treatment delay and survival in bladder cancer Scand J Urol Nephrol 17 1983 163 167
18. S. Maralani, D.P. Wood Jr., and D. Grignon et al. Incidence of urethral involvement in female bladder cancer: an anatomic pathologic study Urology 50 1997 537 541
19. K.K. Aben, and L.A. Kiemeney Epidemiology of bladder cancer Eur Urol 36 1999 660 672
20. A. Brauers, and G. Jakse Epidemiology and biology of human urinary bladder cancer J Cancer Res Clin Oncol 126 2000 575 583
21. S.M. Cohen, T. Shirai, and G. Steineck Epidemiology and etiology of premalignant and malignant urothelial changes Scand J Urol Nephrol Suppl 2000 105 115
22. R. Lee, and M.J. Droller The natural history of bladder cancer. Implications for therapy Urol Clin North Am 27 2000 1 13